PIATTAFORMA PER RICERCA E SVILUPPO DI PROFARMACI BIOTECNOLOGICI INNOVATIVI PER LA CURA DI MALATTIE GENETICHE RARE

Progetto Ministero della Salute- Bando Malattie Rare: "DETERMINANTS OF RESPONSE TO SUBSTITUTIVE/ANTICOAGULANT TREATMENTS IN RARE COAGULATION DISORDERS: FROM MOLECULAR MECHANISMS TO IMPROVED THERAPEUTIC/DIAGNOSTIC" PROTOCOLS

Progetto Bayer Haemophilia Awards Program: Genetic components contributing to the pharmacokinetics of FVIII concentrates

Progetto TELETHON: Non−conventional therapeutic strategies for inherited disorders of hemostasis.

Progetto PRIN: Modulation of Factor VII-Tissue Factor pathway in haemorrhagic and thrombotic diseases

Progetto TELETHON: Genetic and Biochemical Components which Modulate the Individual Risk of Bleeding in Coagulation Factor VII Deficiency

Progetto PRIN: MOLECULAR BASES OF ALTERED PROCOAGULANT AND ANTICOAGULANT FACTOR V FUNCTION IN VASCULAR DISEASES.

Progetto TELETHON: INHERITED ALTERATIONS OF THE PROTHROMBINASE COMPLEX IN THROMBOPHILIAS

CNR Progetto Finalizzato Biotecnologie-Area Ing Molecolare e Biologia Strutturale: "Peptides and antibodies which inhibit or recognize the factor VII-TF complex in thromboembolic disease.

Difetti molecolari della proteina S e del fattore V (cofattori nella via anticoagulante della proteina C) nelle trombofilie eredo-familiari